scholarly journals Stress-induced regulation of eukaryotic elongation factor 2 kinase by SB 203580-sensitive and −insensitive pathways

2002 ◽  
Vol 367 (2) ◽  
pp. 525-532 ◽  
Author(s):  
Axel KNEBEL ◽  
Claire E. HAYDON ◽  
Nick MORRICE ◽  
Philip COHEN
Keyword(s):  
Protein Kinase ◽  
Elongation Factor ◽  
Elongation Factor 2 ◽  
Eukaryotic Elongation Factor 2 ◽  
Eukaryotic Elongation Factor ◽  
Tnf Α ◽  
High Concentrations ◽  
Eef2 Kinase ◽  
Sb 203580

Eukaryotic elongation factor 2 (eEF2) kinase, the enzyme that inactivates eEF2, is controlled by phosphorylation. Previous work showed that stress-activated protein kinase 4 (SAPK4, also called p38Δ) inhibits eEF2 kinase in vitro by phosphorylating Ser-359, while ribosomal protein S6 kinases inhibit eEF2 kinase by phosphorylating Ser-366 [Knebel, Morrice and Cohen (2001) EMBO J. 20, 4360—4369; Wang, Li, Williams, Terada, Alessi and Proud (2001) EMBO J. 20, 4370—4379]. In the present study we have examined the effects of the protein synthesis inhibitor anisomycin and tumour necrosis factor-α (TNF-α) on the phosphorylation of eEF2 kinase. We demonstrate that Ser-359, Ser-366 and two novel sites (Ser-377 and Ser-396) are all phosphorylated in human epithelial KB cells, but only the phosphorylation of Ser-359 and Ser-377 increases in response to these agonists and correlates with the dephosphorylation (activation) of eEF2. Ser-377 is probably a substrate of MAPKAP-K2/K3 (mitogen-activated protein kinase-activated protein kinase 2/kinase 3) in cells, because eEF2 kinase is phosphorylated efficiently by these protein kinases in vitro and phosphorylation of this site, induced by TNF-α and low (but not high) concentrations of anisomycin, is prevented by SB 203580, which inhibits SAPK2a/p38, their ‘upstream’ activator. The phosphorylation of Ser-359 induced by high concentrations of anisomycin is probably catalysed by SAPK4/p38Δ in cells, because no other stress-activated, proline-directed protein kinase tested phosphorylates this site in vitro and phosphorylation is insensitive to SB 203580. Interestingly, the phosphorylation of Ser-359 induced by TNF-α or low concentrations of anisomycin is suppressed by SB 203580, indicating that phosphorylation is also mediated by a novel pathway. Since the phosphorylation of Ser-377 does not inhibit eEF2 kinase in vitro, our results suggest that anisomycin or TNF-α inhibit eEF2 kinase via the phosphorylation of Ser-359.

scholarly journals Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains

2012 ◽  
Vol 442 (1) ◽  
pp. 105-118 ◽  
Author(s):  
Craig R. Pigott ◽  
Halina Mikolajek ◽  
Claire E. Moore ◽  
Stephen J. Finn ◽  
Curtis W. Phippen ◽  
...  
Keyword(s):  
Protein Kinase ◽  
Catalytic Domain ◽  
Functional Organization ◽  
Elongation Factor ◽  
Kinase Domain ◽  
Conserved Residues ◽  
Elongation Factor 2 ◽  
Eukaryotic Elongation Factor 2 ◽  
Kinase Catalytic Domain ◽  
Eukaryotic Elongation Factor

eEF2K (eukaryotic elongation factor 2 kinase) is a Ca2+/CaM (calmodulin)-dependent protein kinase which regulates the translation elongation machinery. eEF2K belongs to the small group of so-called ‘α-kinases’ which are distinct from the main eukaryotic protein kinase superfamily. In addition to the α-kinase catalytic domain, other domains have been identified in eEF2K: a CaM-binding region, N-terminal to the kinase domain; a C-terminal region containing several predicted α-helices (resembling SEL1 domains); and a probably rather unstructured ‘linker’ region connecting them. In the present paper, we demonstrate: (i) that several highly conserved residues, implicated in binding ATP or metal ions, are critical for eEF2K activity; (ii) that Ca2+/CaM enhance the ability of eEF2K to bind to ATP, providing the first insight into the allosteric control of eEF2K; (iii) that the CaM-binding/α-kinase domain of eEF2K itself possesses autokinase activity, but is unable to phosphorylate substrates in trans; (iv) that phosphorylation of these substrates requires the SEL1-like domains of eEF2K; and (v) that highly conserved residues in the C-terminal tip of eEF2K are essential for the phosphorylation of eEF2, but not a peptide substrate. On the basis of these findings, we propose a model for the functional organization and control of eEF2K.

scholarly journals Insights Into the Pathologic Roles and Regulation of Eukaryotic Elongation Factor-2 Kinase

2021 ◽  
Vol 8 ◽  
Author(s):  
Darby J. Ballard ◽  
Hao-Yun Peng ◽  
Jugal Kishore Das ◽  
Anil Kumar ◽  
Liqing Wang ◽  
...  
Keyword(s):  
Protein Synthesis ◽  
Protein Kinase ◽  
Elongation Factor ◽  
Protein Translation ◽  
Negative Regulator ◽  
Translation Elongation ◽  
Elongation Factor 2 ◽  
Global Rate ◽  
Eukaryotic Elongation Factor 2 ◽  
Eukaryotic Elongation Factor

Eukaryotic Elongation Factor-2 Kinase (eEF2K) acts as a negative regulator of protein synthesis, translation, and cell growth. As a structurally unique member of the alpha-kinase family, eEF2K is essential to cell survival under stressful conditions, as it contributes to both cell viability and proliferation. Known as the modulator of the global rate of protein translation, eEF2K inhibits eEF2 (eukaryotic Elongation Factor 2) and decreases translation elongation when active. eEF2K is regulated by various mechanisms, including phosphorylation through residues and autophosphorylation. Specifically, this protein kinase is downregulated through the phosphorylation of multiple sites via mTOR signaling and upregulated via the AMPK pathway. eEF2K plays important roles in numerous biological systems, including neurology, cardiology, myology, and immunology. This review provides further insights into the current roles of eEF2K and its potential to be explored as a therapeutic target for drug development.

scholarly journals Μελέτη μορίων του πρωτόζωου Leishmania που εμπλέκονται στην πρόοδο του κυτταρικού κύκλου

2014 ◽  
Author(s):  
Αλέξανδρος Αλεξανδράτος
Keyword(s):  
Heat Shock ◽  
Elongation Factor ◽  
Alpha Subunit ◽  
Elongation Factor 2 ◽  
Mitochondrial Processing Peptidase ◽  
Eukaryotic Elongation Factor 2 ◽  
Eukaryotic Elongation Factor ◽  
Processing Peptidase

Τα είδη του γένους Leishmania αποτελούν υποχρεωτικά ενδοκυττάρια πρωτοζωικά παράσιτα που προκαλούν ένα ευρύ φάσμα ασθενειών, τις λεισμανιάσεις. Η λεϊσμανίαση θεωρείται νόσος εξέχουσας σπουδαιότητας, με 2 εκατομμύρια νέα κρούσματα το χρόνο, χρήζουσας μεγάλης κοινωνικής και οικονομικής σημασίας. Για τον έλεγχο των συνεχώς αυξανόμενων κρουσμάτων, είναι επιτακτική ανάγκη η ανάπτυξη νέων μη-τοξικών φαρμάκων που θα στοχεύουν σε μόρια-στόχους σημαντικά για την ολοκλήρωση του παρασιτικού κύκλου ζωής. Κατ’ αυτόν τον τρόπο κρίνεται απαραίτητη η μελέτη μηχανισμών και παραγόντων μολυσματικότητας του παρασίτου, που ελέγχουν τον κυτταρικό κύκλο και τη διαφοροποίηση του παρασίτου. Στα πλαίσια αυτά, έχει δειχθεί ότι η επισωμική υπερέκφραση της συνδετικής ιστόνης Η1 του παρασίτου Leishmania (LeishH1) οδηγεί στην καθυστέρηση της ολοκλήρωσης του κυτταρικού κύκλου, αλλά παράλληλα και στη μείωση του ρυθμού διαφοροποίησης των παρασίτων από προμαστιγωτές σε αμαστιγωτές μορφές, έχοντας σαν αποτέλεσμα τη μείωση της μολυσματικότητας του παρασίτου τόσο in vitro όσο και in vivo. Στόχος αυτής της διατριβής ήταν η ανάδειξη μορίων που επηρεάζουν τη μολυσματικότητα του παρασίτου, μελετώντας το προτέωμα των μη μολυσματικών παρασίτων που υπερεκφράζουν την LeishH1. Η συγκριτική μελέτη των παρασίτων που υπερεκφράζουν τη LeishH1 σε σχέση με τα παράσιτα ελέγχου, είχε επίσης ως σκοπό την περαιτέρω μελέτη του βιολογικού ρόλου της LeishH1 στα παράσιτα και τη διερεύνηση του ρόλου της στη γονιδιακή ρύθμιση του παρασίτου. Η συγκριτική πρωτεομική ανάλυση με ηλεκτροφόρηση δυο-διαστάσεων, των παρασίτων που υπερεκφράζουν την LeishH1 σε σχέση με τα παράσιτα ελέγχου, κατέδειξε πως μόνο μια μικρή ομάδα πρωτεϊνών παρουσιάζει διαφορική έκφραση. Συγκεκριμένα, τρεις πρωτεΐνες [heat shock protein 83 (HSP83), eukaryotic elongation factor 2(eEF-2), alpha subunit of the mitochondrial processing peptidase (α-MPP)] παρουσιάζουν χαμηλότερα επίπεδα έκφρασης ενώ άλλες δυο (α/β τουμπουλίνη, ΜΑΡ) παρουσιάζουν μεγαλύτερη κατανομή έκφρασης. Πειράματα αλυσιδωτής αντίδρασης πολυμεράσης αντίστροφης μεταγραφάσης πραγματικού χρόνου, επιβεβαίωσαν το αποτέλεσμα αυτό, υποδηλώνοντας ότι η LeishH1 δεν είναι γενικός καταστολέας της μεταγραφής αλλά επηρεάζει ένα ειδικό υποσύνολο πρωτεϊνών, σε προ- ή μετα-μεταγραφικό επίπεδο. Ανάμεσα στις πρωτεΐνες με διαφορική έκφραση ήταν και η τουμπουλίνη. Η διαφορική έκφραση της πρωτεΐνης αντικατοπτρίζεται άμεσα στη μορφολογία των παρασίτων που υπερεκφράζουν την LeishH1, καθώς τα παράσιτα αυτά παρουσιάζουν μικρότερο και πιο στρογγυλό σχήμα και μεγαλύτερη μορφολογική ετερογένεια. Μια ακόμα πρωτεΐνη με διαφορική έκφραση, ήταν και η HSP83, η οποία παρουσίασε χαμηλότερα επίπεδα. Θέλοντας να εξακριβώσουμε σε ποιο επίπεδο παρεμβαίνει η LeishH1 στο μηχανισμό έκφρασης της HSP83, συγκρίναμε τα επίπεδα του mRNA και η ανάλυση κατέδειξε ότι δεν υπάρχουν διαφορές στα επίπεδα αυτά. Επίσης, μελετήθηκε ο ρυθμός έκφρασης της πρωτεΐνης μέσω της μεταβολικής σήμανσης των πρωτεϊνών και αποκαλύφθηκε πως σε αυτό το στάδιο εντοπίζεται η παρεμβολή της LeishH1, καθώς τα παράσιτα που την υπερεκφράζουν παρουσιάζουν χαμηλότερο ρυθμό έκφρασης της HSP83. Συμπερασματικά διαφαίνεται πως υπάρχει μια συσχέτιση μεταξύ μονοπατιών που εμπλέκονται στην αντίσταση έναντι φαρμακευτικών ουσιών, στην απόπτωση και τη μολυσματικότητα. Κατ’ αυτόν τον τρόπο, τα ειδικά σήματα και οι μηχανισμοί που ρυθμίζουν τη διαφοροποίηση/μολυσματικότητα του παρασίτου και την απόπτωση/απόκριση στο στρες, χρήζουν περαιτέρω διερεύνησης καθώς φαίνεται να αποτελούν τις δυο όψεις του ίδιου νομίσματος.

scholarly journals Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase

2012 ◽  
Vol 442 (3) ◽  
pp. 681-692 ◽  
Author(s):  
Sébastien Pyr Dit Ruys ◽  
Xuemin Wang ◽  
Ewan M. Smith ◽  
Gaëtan Herinckx ◽  
Nusrat Hussain ◽  
...  
Keyword(s):  
Catalytic Domain ◽  
Elongation Factor ◽  
Translation Elongation ◽  
Intact Cells ◽  
Elongation Factor 2 ◽  
Eukaryotic Elongation Factor 2 ◽  
293 Cells ◽  
Eukaryotic Elongation Factor ◽  
A Site

eEF2K [eEF2 (eukaryotic elongation factor 2) kinase] phosphorylates and inactivates the translation elongation factor eEF2. eEF2K is not a member of the main eukaryotic protein kinase superfamily, but instead belongs to a small group of so-called α-kinases. The activity of eEF2K is normally dependent upon Ca2+ and calmodulin. eEF2K has previously been shown to undergo autophosphorylation, the stoichiometry of which suggested the existence of multiple sites. In the present study we have identified several autophosphorylation sites, including Thr348, Thr353, Ser366 and Ser445, all of which are highly conserved among vertebrate eEF2Ks. We also identified a number of other sites, including Ser78, a known site of phosphorylation, and others, some of which are less well conserved. None of the sites lies in the catalytic domain, but three affect eEF2K activity. Mutation of Ser78, Thr348 and Ser366 to a non-phosphorylatable alanine residue decreased eEF2K activity. Phosphorylation of Thr348 was detected by immunoblotting after transfecting wild-type eEF2K into HEK (human embryonic kidney)-293 cells, but not after transfection with a kinase-inactive construct, confirming that this is indeed a site of autophosphorylation. Thr348 appears to be constitutively autophosphorylated in vitro. Interestingly, other recent data suggest that the corresponding residue in other α-kinases is also autophosphorylated and contributes to the activation of these enzymes [Crawley, Gharaei, Ye, Yang, Raveh, London, Schueler-Furman, Jia and Cote (2011) J. Biol. Chem. 286, 2607–2616]. Ser366 phosphorylation was also detected in intact cells, but was still observed in the kinase-inactive construct, demonstrating that this site is phosphorylated not only autocatalytically but also in trans by other kinases.

scholarly journals Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis

2012 ◽  
Vol 123 (1) ◽  
pp. 164-178 ◽  
Author(s):  
Bárbara González-Terán ◽  
José R. Cortés ◽  
Elisa Manieri ◽  
Nuria Matesanz ◽  
Ángeles Verdugo ◽  
...  
Keyword(s):  
Elongation Factor ◽  
Elongation Factor 2 ◽  
Eukaryotic Elongation Factor 2 ◽  
Eukaryotic Elongation Factor ◽  
Tnf Α

Abstract 204: Protective Roles of Eukaryotic Elongation Factor 2 Kinase on Rat Cardiomyoblast Death Under Glucose-deprived Condition

2017 ◽  
Vol 121 (suppl_1) ◽  
Author(s):  
Satoshi Kameshima ◽  
Muneyoshi Okada ◽  
Hideyuki Yamawaki
Keyword(s):  
Cell Death ◽  
Protein Kinase ◽  
Caspase 3 ◽  
Elongation Factor ◽  
H9c2 Cell ◽  
H9c2 Cells ◽  
Nuclear Condensation ◽  
Elongation Factor 2 ◽  
Eukaryotic Elongation Factor 2 ◽  
Eukaryotic Elongation Factor

Eukaryotic elongation factor 2 (eEF2) kinase (eEF2K; also known as calmodulin-dependent protein kinase III) has both active and inactive phosphorylation sites. An intracellular energy sensor, AMP-activated protein kinase (AMPK) was reported to activate eEF2K via increasing dephosphorylation at Ser366 (inactive site). Activated eEF2K phosphorylates and inactivates a specific substrate, eEF2, which results in the inhibition of protein translation consuming high energy. Glucose depletion (GD) is one of the primary causes for cardiomyocyte death in the developed cardiac hypertrophy. We have recently found that the expression and dephosphorylation of eEF2K (Ser366) and eEF2 phosphorylation were significantly increased in left ventricle of several cardiac hypertrophy models. However, it is almost unknown whether eEF2K/eEF2 signals affect GD-induced cardiomyocyte death. The aim of this study was to explore it. GD was induced by incubating H9c2 cells in a glucose-free medium. H9c2 cell viability, apoptotic-like nuclear condensation or protein expression was examined using a cell counting assay, DAPI staining or Western blotting, respectively. GD induced H9c2 cell death (p<0.01, n=6) and caspase-3 fragmentation (p<0.05, n=10-12). In addition, GD significantly increased phosphorylation of AMPK (p<0.05, n=6-8) and eEF2 (p<0.01, n=4-8) as well as eEF2K dephosphorylation at Ser366 (p<0.01, n=4-8). eEF2K gene knockdown (eEF2K KD) by siRNA transfection significantly increased GD-induced H9c2 cell death (p<0.05, n=7) and caspase-3 fragmentation (p<0.01, n=9). Moreover, eEF2K KD significantly facilitated GD-induced increase of nuclear condensation (44.0±3.3%, eEF2K siRNA vs. 30.9±2.4%, control siRNA p<0.01, n=5). AMPK KD did not affect GD-induced H9c2 cell death and eEF2K dephosphorylation. In conclusion, we for the first time revealed in H9c2 cells that activated eEF2K might play protective roles in GD-induced apoptosis via the inhibition of caspase-3 fragmentation, whereas AMPK activation is not directly related to the regulation of eEF2K/eEF2 signals in GD condition. The present results suggest eEF2K as a novel pharmacotherapeutic target for cardiac dysfunction.

Abstract 274: Expression and Phosphorylation States of Eukaryotic Elongation Factor 2 (EEF2) and EEF2 Kinase in Cardiomyocytes From Hypertrophy Models

2016 ◽  
Vol 119 (suppl_1) ◽  
Author(s):  
Satoshi Kameshima ◽  
Muneyoshi Okada ◽  
Shiro Ikeda ◽  
Yuki Watanabe ◽  
Hideyuki Yamawaki
Keyword(s):  
Protein Synthesis ◽  
Cardiac Hypertrophy ◽  
Elongation Factor ◽  
Protein Translation ◽  
Cardiomyocyte Hypertrophy ◽  
Specific Substrate ◽  
Elongation Factor 2 ◽  
Eukaryotic Elongation Factor 2 ◽  
Eukaryotic Elongation Factor ◽  
Eef2 Kinase

Eukaryotic elongation factor 2 (eEF2) kinase (eEF2K, also known as calmodulin (CaM)-dependent protein kinase III) is regulated by both CaM-dependent and -independent mechanisms. Activated eEF2K phosphorylates and inactivates a specific substrate, eEF2. eEF2 activation facilitates protein translation. It is recognized that increased protein synthesis is one of the primary factors for cardiomyocyte hypertrophy. In fact, angiotensin II, which induces cardiomyocyte hypertrophy, was reported to facilitate eEF2 dephosphorylation (activation) and protein synthesis in rat isolated cardiomyocytes. We have previously demonstrated that protein expression of eEF2K was increased specifically in left ventricles (LV) of spontaneously hypertensive rats (SHR). However, expression and phosphorylation states of eEF2K and eEF2 in LV of other cardiac hypertrophy models are unknown. The aim of this study was to explore it. Male C57BL/6NJcl mice and Wistar rats received transverse aortic constriction (TAC) and isoproterenol (5 mg/kg; ISO) injection, respectively, which induced cardiac hypertrophy. After 3 and 28 days from TAC operation and 7 days from ISO injection, LV were isolated and used for Western blotting (WB) and immunohistochemistry (IHC). Echocardiography was done in TAC mice before LV isolation. In TAC-induced hypertrophied LV (3 days), eEF2K expression was significantly increased (p<0.01 vs. SHAM) and its phosphorylation at Ser366 was significantly decreased (p<0.05 vs. SHAM). Consistently, eEF2 phosphorylation was significantly increased (p<0.01 vs. SHAM). In LV from ISO rats, eEF2K phosphorylation at Ser366 was significantly decreased as determined by WB (p<0.01 vs. control). In addition, eEF2K- and phosphorylated eEF2-positive cardiomyocytes were increased as determined by IHC. These changes were also confirmed in LV from SHR. At 28 days after TAC, fractional shortening was significantly decreased (from 56.6±1.6% to 44.4±2.3%, p<0.01). Interestingly, eEF2 phosphorylation in LV was significantly decreased (p<0.05 vs. SHAM). The present results suggest the potential role of eEF2K/eEF2 signals in the pathogenesis of cardiac hypertrophy/failure.

Sign in / Sign up

Export Citation Format

Share Document